We Announced the $48.3M Federal Partnership at the White House!
It was incredibly special for me to speak at the White House on Wednesday about our funding from the federal government and what it will mean for patients like me.
While on stage, I couldn’t help but think back to 14 years ago when I was fighting for my life in the ICU. I never could have imagined that one day I would be able to turn those horrible moments into a mission with the potential to help millions of patients all over the world.
The Wall Street Journal Profiled Our Repurposing Work to Help Patients like Kaila
Amy Marcus of the Wall Street Journal profiled Every Cure, the drug repurposing landscape, and patients like Kaila whose life was saved thanks to repurposed drugs that we uncovered! Click here to read the full article.
We are building an AI platform that aims to identify treatments for millions of patients
Every Cure is scaling the approach I used to discover my own cure to unlock additional life-saving uses for every drug. We are using the federal funding to leverage novel AI techniques to analyze the world’s biomedical knowledge and identify 100 potential treatment opportunities in the next five years and advance 25 into further research, including clinical trials. Promising early leads include arginine for sickle cell disease, folinic acid for autism spectrum disorder, and bosutinib for ALS.
Wow, my head is spinning from these recent clinical trial results. Within minutes of one another, two conflicting studies were released. The first I’ll highlight is of tocilizumab (the drug that my friend and colleague Kazu Yoshizaki developed to treat Castleman disease and tested on himself to prove that it was safe before giving it…
With doctors and researchers around the world searching for effective treatments for COVID-19, many drugs approved to treat other diseases are being used in hopes that they’ll be effective against the virus, a use that’s known as “off-label.” A volunteer army that Dr. David Fajgenbaum assembled has catalogued every use documented in medical literature so…
Repurposing existing drugs to treat COVID19 provides our best opportunity to save lives ASAP. As I like to say, we’ve got to teach old dogs new tricks! I know the power of drug repurposing: I’m alive today thanks to a repurposed drug. Given the overlap between COVID19 and Castleman disease, I’ve suspected that treatments used…
You’ve probably seen the term “cytokine storm” in the news a lot recently. That’s because COVID19 is able to unleash a cytokine storm in the most sick cases. As someone who has survived 5 deadly COVID19-like cytokine storms due to idiopathic multicentric Castleman disease and who studies cytokine storms in my lab, I thought I’d…
As I was driving down to North Carolina to visit my family at the beginning of the COVID-19 global pandemic, I found myself hoping and praying that COVID-19 would not have the kind of impact that was being projected. This wasn’t the first time I hoped and prayed for something that felt so out of…
